BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 23568995)

  • 1. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
    Kanemaru K
    Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
    Gadad BS; Britton GB; Rao KS
    J Alzheimers Dis; 2011; 24 Suppl 2():223-32. PubMed ID: 21460436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
    Khanam H; Ali A; Asif M; Shamsuzzaman
    Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
    Naeem A; Fazili NA
    Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic acid aptamers for neurodegenerative diseases.
    Bouvier-Müller A; Ducongé F
    Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurodegenerative conformational disease and its molecular bases].
    Li WW; Cai DF; Ren HM
    Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegenerative lesions: seeding and spreading.
    Duyckaerts C
    Rev Neurol (Paris); 2013 Oct; 169(10):825-33. PubMed ID: 24035591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.
    Valera E; Spencer B; Masliah E
    Neurotherapeutics; 2016 Jan; 13(1):179-89. PubMed ID: 26494242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaperone-like antibodies targeting misfolded tau protein: new vistas in the immunotherapy of neurodegenerative foldopathies.
    Zilka N; Kontsekova E; Novak M
    J Alzheimers Dis; 2008 Oct; 15(2):169-79. PubMed ID: 18953106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of antibodies in non-infectious neurodegenerative diseases.
    Krishnamurthy PK; Sigurdsson EM
    N Biotechnol; 2011 Sep; 28(5):511-7. PubMed ID: 21473943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
    Fatima MT; Islam Z; Ahmad E; Salahuddin P
    Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are neurodegenerative diseases "protein cancers"?].
    Hasegawa M
    Brain Nerve; 2012 Jun; 64(6):675-9. PubMed ID: 22647475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding.
    Ho L; Pasinetti GM
    Expert Rev Proteomics; 2010 Aug; 7(4):579-89. PubMed ID: 20653511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for Alzheimer's disease.
    Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
    Arawaka S; Machiya Y; Kato T
    Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.